Top Markets
Coin of the day
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Rankning i aktier #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Aktiekurs
$14.66
Senast synkroniserad: 2026-08-28
Marknadsvärde
$839.37M
Förändring (1 dag)
-2.67%
Förändring (1 år)
557.32%
Land
US
Handel Climb Bio, Inc. (CLYM)

Kategori

Historik för aktiesplit för Climb Bio, Inc. (CLYM)
Aktien Climb Bio, Inc. (symbol: CLYM) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 30, 2026.
En CLYM-aktie köpt före Aug 30, 2026 motsvarar nu 0 CLYM-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH